Clintech Lab IPO: Overwhelming Response! Subscribed 39 Times by Day 3—Don’t Miss the Details
The initial public offering (IPO) of Clintech Laboratory Limited opened for subscription on July 25 and will close on July 29. As of July 29, the SME IPO was subscribed over 38.96 times.
Clintech Laboratory Limited offers various diagnostic and health testing services. The company conducts more than 150 different tests, including Biochemical, Immunology, Hematology, Molecular Biology, Serology, Microbiology, and Histopathology tests.
Clintech Lab IPO Subscription Details
On the third day of the IPO, it received 2,22,55,200 share applications against the 5,71,200 shares on offer. The retail category received 1,49,41,200 applications, while the Non-Institutional Investor (NII) category received 70,12,800 applications.
Clintech Lab IPO Details
The Clintech Lab IPO is a fixed-price offering, aiming to raise ₹5.78 crore by issuing 6.02 lakh new shares at ₹96 per share. The minimum lot size for investment is 1,200 shares, requiring retail investors to invest at least ₹115,200.
Inventure Merchant Banker Services Pvt Ltd is the lead manager for the IPO, and Bigshare Services Pvt Ltd is the registrar. Svcm Securities is the market maker for the IPO.
Disclaimer: The views and investment tips expressed by investment experts on Sharepriceindia.com are their own and not those of the website or its management. Sharepriceindia.com advises users to check with certified experts before taking any investment decisions.
